Collastat Absorbable Collagen Hemostatic Sponge, Collastat Absorbable Collagen Hemostatic - Microfibrillar Form
FDA premarket approval P810006/S082 · decided 2018-05-17
Approval details
- PMA number
- P810006
- Supplement
- S082
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Collastat Absorbable Collagen Hemostatic Sponge, Collastat Absorbable Collagen Hemostatic - Microfibrillar Form
- Generic name
- Agent, absorbable hemostatic, collagen based
- Applicant
- Integra LifeSciences Corporation
- Date received
- 2018-04-20
- Decision date
- 2018-05-17
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- LMF
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Planisboro, NJ
- Statement
- Change in the environmental monitoring procedures for detection of bioburden at the main cleanroom manufacturing area.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.